FCGR2B and triple-A syndrome: Our study reveals expression of activating, γ‐chain‐associated FcγR (human IA and IIIA; mouse I, III, and IV) and inhibitory ITIM‐bearing FcγRIIB (human/mouse) in the media and adventitia of AAA lesions.